We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Published in the Commonwealth of Australia Gazette No. GN 1, 13 January 2010
THERAPEUTIC GOODS ACT 1989
I, PETER BIRD, Acting Head – Office of Non-Prescription Medicines, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of Section 42DF(1) of the Therapeutic Goods Act 1989, give notice that the restricted representation described in paragraph (a), has been approved for use in advertisements directed to consumers, for the products listed in paragraph (b) below:
- Representations to the effect that advertisements to consumers for the goods described in paragraph (b) may refer to:
- "do not use if you have stomach ulcers;"
- Voltaren Rapid 12.5 (AUST R 125889)
Voltaren Rapid 25 (AUST R 42942) - sponsored by Novartis Consumer Health Australasia Pty Ltd.
Dated this 18th day of December 2009
PETER BIRD
Delegate of the Secretary to the Department of Health and Ageing